HCV-TARGET study group. Effectiveness of ledipasvir-sofosbuvir combination in patients with hepatitis C virus infection and factors associated with sustained virologic response

Terrault NA, Zeuzem S, Di Bisceglie AM, Lim JK, Pockros PJ, Frazier LM, et al. HCV-TARGET study group. Effectiveness of ledipasvir-sofosbuvir combination in patients with hepatitis C virus infection and factors associated with sustained virologic response. Gastroenterology. 2016;151(6):1131-1140.e5.

Publication Type:

Journal Article

Authors:

N A Terrault; Stefan Zeuzem; A M Di Bisceglie; Lim, JK; Pockros, PJ.; Frazier, LM.; Kuo, A.; Lok, AS.; Shiffman, ML.; Ben Ari, Z.; Akushevich, L.; Vainorius, M.; M S Sulkowski; Fried, MW.; David R. Nelson

Source:

Gastroenterology, Volume 151, Issue 6, p.1131-1140.e5 (2016)

Notes:

PMID:27565882.

Cited On:

Export Citation:
RIS Format
Top